LAB vs LYB · rev $174.4M vs P/E 21, rev $40.30B
Standard Biotools Inc (LAB) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported LYB revenue for 2024-12-31 was $40.30B. Net income was $1.37B. Revenue was down 2.0% from 2023-12-31 to 2024-12-31. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
LAB currently screens at market cap $317.1M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the LAB and LYB stock pages for the full models.
Not investment advice.